Cargando…

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells

Interleukin-15 (IL-15) is a cytokine that has been shown to expand CD8 T cell and natural killer (NK) cell populations, and therefore has potential for potentiating adoptive immune cell therapy for cancer. Previously, IL-15 has been shown to induce proliferation of CD8 memory T cells through activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watkinson, Fiona, Nayar, Sandeep Krishan, Rani, Aradhana, Sakellariou, Christina A., Elhage, Oussama, Papaevangelou, Efthymia, Dasgupta, Prokar, Galustian, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848219/ https://www.ncbi.nlm.nih.gov/pubmed/33537030 http://dx.doi.org/10.3389/fimmu.2020.594620

Ejemplares similares

Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021)

Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
por: Papaevangelou, Efthymia, et al.
Publicado: (2023)

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model
por: Papaevangelou, Efthymia, et al.
Publicado: (2020)

Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification
por: Esteves, Ana M., et al.
Publicado: (2021)

Robotic urology in the United Kingdom: experience and overview of robotic-assisted cystectomy
por: Elhage, Oussama, et al.
Publicado: (2008)

Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
por: Galustian, Christine, et al.
Publicado: (2022)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

NK and NKT-Like Cells in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)

Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
por: Hickman, Oliver J., et al.
Publicado: (2016)

Oxoisoaporphine as Potent Telomerase Inhibitor
por: Wei, Zu-Zhuang, et al.
Publicado: (2016)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2021)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
por: Eriksson Ström, Jonas, et al.
Publicado: (2018)

CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis
por: Tupin, Emmanuel, et al.
Publicado: (2004)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
por: Mrakovcić-Sutić, Ines, et al.
Publicado: (2002)

Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity
por: Scorpio, Diana G., et al.
Publicado: (2018)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
por: Sokhatska, Oksana, et al.
Publicado: (2019)

Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya
por: Thanapati, Subrat, et al.
Publicado: (2017)

Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2
por: Hickman, Oliver J, et al.
Publicado: (2016)

NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015)

The Effect of Telomerase Inhibition on NK Cell Activity in Acute Myeloid Leukemia
por: Dizaji Asl, Khadijeh, et al.
Publicado: (2023)

Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
por: Tang, Ying, et al.
Publicado: (2013)

Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage
por: Beraza, Naiara, et al.
Publicado: (2009)

Phenotypic and functional analyses of NK and NKT-like populations during the early stages of chikungunya infection
por: Thanapati, Subrat, et al.
Publicado: (2015)

Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells
por: Trittel, Stephanie, et al.
Publicado: (2019)

The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies
por: Ahmadi, Alireza, et al.
Publicado: (2022)

The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients
por: Flores-Gonzalez, Julio, et al.
Publicado: (2022)

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
por: Beckmann, Kerri, et al.
Publicado: (2021)

NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ Production
por: Christaki, Eirini, et al.
Publicado: (2015)

α‐Galactosylceramide‐activated murine NK1.1(+) invariant‐NKT cells in the myometrium induce miscarriages in mice
por: Ichikawa, Tomoko, et al.
Publicado: (2016)

iNKT Cells Suppress Pathogenic NK1.1(+)CD8(+) T Cells in DSS-Induced Colitis
por: Lee, Sung Won, et al.
Publicado: (2018)

Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs
por: Bonamichi, Beatriz Dal Santo Francisco, et al.
Publicado: (2017)

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hteks1abe5i1g32rqp8uun9luc